Despite its diagnostic relevance, FABP2 levels did not significantly correlate with overall survival, limiting its prognostic utility in HCC, since elevated levels likely reflect underlying cirrhosis-related gut–liver axis dysfunction rather than direct oncogenic processes [83]. This evidence concerns the gene FABP2 and hepatocellular carcinoma.